A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
Clinical trial NCT06649695 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06649695
- Sponsor
- European Myeloma Network B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2028-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.